I. V. Boulytcheva
7 Papers
37 Citations
I. V. Boulytcheva is an academic researcher. The author has contributed to research in topics: Chondrosarcoma & Internal medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Expression of Molecular Markers in the Tumor and Survival Prognosis in Osteosarcoma
TL;DR: Analysis of HER-2/neu, p53, and Cox-2 expression in the primary tumor should be taken into consideration in the treatment of patients with osteosarcoma.
35
Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcoma.
N. E. Kushlinskii,A A Alferov,I. V. Boulytcheva,Yu S Timofeev,E A Korotkova,O T Khvan,Yu B Kuzmin,I N Kuznetsov,A V Bondarev,M Yu Shchupak,N Yu Sokolov,M M Efimova,E. S. Gershtein,E A Sushentsov,M. D. Aliev,E R Musaev +15 more
TL;DR: It can be concluded that the ratio between circulating soluble forms of the receptor and the ligand of PD-1/PD-L signaling pathway differs between patients with chondrogenic and those with osteogenic tumors, s PD-L1 being diagnostically valuable mostly for chondrogensic bone neoplasms.
4
Clinical and prognostic significance of the soluble form of the VISTA immunity control point in patients with primary bone tumors.
Nikolai E. Kushlinskii,Olga Vladimirovna Kovaleva,Yu B Kuzmin,E A Korotkova,E. S. Gershtein,I. V. Boulytcheva,E V Kozlova,Dmitry Kudlay,Polina A. Podlesnaya,Alexei Gratchev,I N Kuznetsov,E A Sushentsov +11 more
TL;DR: In this article, a comparative enzyme-linked immunosorbent assay of the content of the soluble form of the VISTA in the blood serum of 30 healthy donors (control group), 79 patients with primary malignant (osteosarcoma - 30, chondrosarcka - 31, chordoma - 14) and 14 borderline (giant cell tumor) bone neoplasms are presented.
3
PD-L1 and PU.1 expression in malignant peripheral nerve sheath tumors
A. T. Abdulzhaliev,I. V. Boulytcheva,Olga V. Kovaleva,E A Sushentsov,Anastasia I. Senderovich,А. K. Valiev,N. E. Kushlinskii +6 more
TL;DR: In this paper , the relationship between PD-L1 expression and development and prognosis of malignant peripheral nerve sheath tumors (MPNSTs) has been determined and the role of tumor microenvironment, in particular tumor-associated macrophages, in solid tumors has been explored.
Expression of Matrix Metalloproteinases 1, 2, 9 and Their Tissue Inhibitor-1 in Cartilage-Forming Osteal Tumors
TL;DR: The expression of MMP-1(+) was significantly associated with 3-year relapse-free and 5-year overall survival of the patients and the expression ofMMP-2 expression in chondrosarcomas did not reflect the main clinical morphological characteristics of the disease and its prognosis.